On September 24, 2026, a clinical trial titled "Posterior Nasal Nerve Combined With Anterior Ethmoid Neurotomy for Idiopathic Rhinitis" was listed as recruiting. The study, registered as NCT06870292, does not have an assigned phase, listed as NA. The trial status reflects recruitment activity as of the stated date, according to the registry record.
This study is associated with vasoactive intestinal peptide, a compound with approved regulatory status in at least one indication. The trial listing does not include results, efficacy data, or safety findings at this stage. No outcome measures or interim data were provided in this update.
Details on trial design, eligibility, or endpoints are available through the official registry listing linked in the source. As recruitment continues, updates to status or phase may be posted in the future. This brief reflects only the recruiting status and title as recorded on the specified date.
Readers interested in background on vasoactive intestinal peptide can consult the compound overview for additional context.